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Population-Based Microcephaly Surveillance in the
United States, 2009 to 2013: An Analysis of
Potential Sources of Variation
Janet D. Cragan*1, Jennifer L. Isenburg1,2, Samantha E. Parker3, C.J. Alverson1,
Robert E. Meyer4, Erin B. Stallings1,2, Russell S. Kirby5, Philip J. Lupo6, Jennifer S. Liu1,7,
Amanda Seagroves1,2, Mary K. Ethen8, Sook Ja Cho9, MaryAnn Evans10,
Rebecca F. Liberman11, Jane Fornoff12, Marilyn L. Browne13, Rachel E. Rutkowski5,
Amy E. Nance14, Marlene Anderka15, Deborah J. Fox13, Amy Steele14, Glenn Copeland16,
Paul A. Romitti17, and Cara T. Mai1, for the National Birth Defects Prevention Network
Background: Congenital microcephaly has been linked to maternal Zika virus
infection. However, ascertaining infants diagnosed with microcephaly can be
challenging. Methods: Thirty birth defects surveillance programs provided
data on infants diagnosed with microcephaly born 2009 to 2013. The pooled
prevalence of microcephaly per 10,000 live births was estimated overall and
by maternal/infant characteristics. Variation in prevalence was examined
across case finding methods. Nine programs provided data on head
circumference and conditions potentially contributing to microcephaly.
Results: The pooled prevalence of microcephaly was 8.7 per 10,000 live
births. Median prevalence (per 10,000 live births) was similar among
programs using active (6.7) and passive (6.6) methods; the interdecile range
of prevalence estimates was wider among programs using passive methods
for all race/ethnicity categories except Hispanic. Prevalence (per 10,000 live
births) was lowest among non-Hispanic Whites (6.5) and highest among non-
Hispanic Blacks and Hispanics (11.2 and 11.9, respectively); estimates
followed a U-shaped distribution by maternal age with the highest prevalence
among mothers <20 years (11.5) and 40 years (13.2). For gestational age
and birth weight, the highest prevalence was among infants <32 weeks
gestation and infants <1500 gm. Case definitions varied; 41.8% of cases had
an HC  the 10th percentile for sex and gestational age. Conclusion:
Differences in methods, population distribution of maternal/infant
characteristics, and case definitions for microcephaly can contribute to the
wide range of observed prevalence estimates across individual birth defects
surveillance programs. Addressing these factors in the setting of Zika virus
infection can improve the quality of prevalence estimates.
Birth Defects Research (Part A) 106:972–982, 2016.
VC 2016 Wiley Periodicals, Inc.
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Introduction
Since the first reports of an increased number of infants
born with microcephaly in Brazil in September 2015, great
strides have been made in characterizing the causal
relationship between Zika virus infection during pregnancy
and congenital microcephaly, as well as other serious brain
abnormalities (Rasmussen et al., 2016; Schuler-Faccini
et al., 2016). This work emphasized the value of
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comprehensive population-based surveillance data on these
defects. The National Birth Defects Prevention Network
(NBDPN) was established in 1997 with the mission of
improving population-based surveillance of birth defects in
the United States (http://www.nbdpn.org). Since 2000, the
NBDPN has released annual reports containing state-specific,
population-based data on the prevalence of major birth
defects; however, ascertaining infants with microcephaly can
present challenges for birth defects surveillance programs.
To illustrate, the prevalence of microcephaly for the
years 2006 to 2010 estimated by surveillance programs
included in the NBDPN Annual Report 2013 ranged from
0.5 to 19.0 per 10,000 live births (Mai et al., 2013). Differ-
ences in the clinical definition of microcephaly, the timing
and setting of diagnosis, case ascertainment methods, and
other factors may have contributed to this wide variation
in observed prevalence. For these reasons, microcephaly
was dropped from the list of defects requested in the
NBDPN Annual Report in 2014 (Mai et al., 2014), but
many programs have continued to monitor its prevalence.
The purpose of this report is to describe the estimated
prevalence of microcephaly in the United States from 2009
to 2013 using data from thirty population-based birth
defects surveillance programs and to explore potential rea-
sons for some of the observed variation in prevalence.
BACKGROUND ON MICROCEPHALY
Microcephaly is the clinical finding of a small head when
compared with infants of the same sex and age, or gesta-
tional age if measured at birth. The head circumference
(HC), also known as the occipitofrontal circumference, is
used to assess the volume of the underlying brain (Bray
et al., 1969; Cooke et al., 1977). Measurements of HC are
compared with standard references and described in
terms of percentiles or SDs above or below the mean for
the reference population. Clinicians can differ in the refer-
ence value they use as the threshold for defining micro-
cephaly or as a trigger for evaluation of an infant for an
underlying abnormality. Commonly used thresholds are
less than 3rd percentile or more than 2 SD below the
mean. Other thresholds used are less than the 5th or 10th
percentiles, or more than 3 SDs below the mean (Opitz
and Holt, 1990; Raymond and Holmes, 1994; Ashwal et al.,
2009). Complicating classification further is that measure-
ment of HC in the newborn or young infant can be inaccu-
rate due to molding of the head following vaginal birth,
infant movement, use of tapes that measure only to the
nearest half centimeter, and other factors. It is critical to
assess head growth, and thus growth of the brain, routine-
ly throughout childhood (Holden, 2014). Microcephaly is
confirmed when repeated HC measurements over time
remain smaller than expected, or become progressively
smaller, compared with infants of the same sex and age.
While the finding of a small HC may suggest an abnor-
mality in the underlying brain, it does not confirm an
abnormality or define its nature. Some infants who are
constitutionally small overall will have an HC below a giv-
en threshold without any underlying brain abnormality.
Others may have a small HC due to limitations on growth
in utero that are unrelated to brain structure or function.
Microcephaly is disproportionate when the HC is small in
proportion to infant length and weight, which may be nor-
mal for sex and age; or proportionate when the HC, length,
and weight are all small for the infant’s sex and age, but
proportional to each other (Leviton et al., 2002). In con-
genital microcephaly, the decreased HC is present prena-
tally or at the time of delivery. However, microcephaly can
be acquired postnatally due to a delivery complication or
a subsequent insult, such as infection or trauma (Baxter
et al., 2009; von der Hagen et al., 2014). In addition,
microcephaly that is due to a genetic syndrome may not
be present at birth but develop postnatally.
Although most cases of congenital microcephaly have
unknown etiology, some causes of congenital microcephaly
have been identified (Ashwal et al., 2009). Microcephaly is a
known component of some chromosomal abnormalities and
single gene disorders (Opitz and Holt, 1990). It is a compo-
nent of fetal alcohol syndrome and a manifestation of several
congenital infections (e.g., cytomegalovirus, toxoplasmosis,
and rubella). Congenital microcephaly has been associated
with other exposures or conditions including placental insuf-
ficiency in utero, poorly controlled maternal diabetes, high
levels of radiation exposure, and in utero exposure to the
medication hydantoin. The clinical implications, natural histo-
ry, and developmental potential for infants with microcephaly
vary depending on the cause and severity.
Taken together, variations in how microcephaly is
defined, the existence of different types, the timing of diag-
nosis, and the accuracy of gestational age estimates at birth
can contribute to variation in the reported prevalence of
microcephaly. Microcephaly surveillance is particularly chal-
lenging when programs use different methods in terms of
the settings where cases are identified (e.g., birth hospitals
only, birth and pediatric hospitals, out-patient specialty clin-
ics) and the maximum age at which affected children are
ascertained (e.g., newborn only, up to 1 year, up to 3 years).
For many programs, limitations on types of data sources
and time period for case ascertainment and follow-up are
critical. However, the recent increased focus on microcepha-
ly as a consequence of congenital Zika virus infection has
led to heightened interest in re-examining the epidemiolog-
ic characteristics of microcephaly and improving case ascer-
tainment of this condition.
Materials and Methods
The NBDPN issued a call to state and territorial birth
defects surveillance programs for data on infants born
from 2009 to 2013 who have a diagnosis of microcephaly
(see Supplementary Materials, which are avaiable online).
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A total of thirty programs provided data. Typically, cases
were identified by the presence of an ICD-9-CM hospital
discharge code for microcephaly or mention of microceph-
aly in the medical record regardless of the HC size. One
program was known to have required that the HC mea-
surement be less than the 3rd percentile by sex and gesta-
tional age for inclusion in the surveillance. Data provided
for each case included the year of birth, maternal race/eth-
nicity and age at delivery, infant sex, gestational age, birth
weight, and plurality. Eight programs also provided infor-
mation on the specific HC measurement or value of the HC
percentile for each case; a ninth provided the number of
cases within categories of HC percentiles. These nine pro-
grams also included data on the infant’s age at the time of
the first HC measurement ascertained by the surveillance
program, whether the certainty of the microcephaly diagno-
sis was considered confirmed (definite) or questionable
(possible/probable), and the presence of additional condi-
tions that might contribute to microcephaly.
Participating programs were divided into those with
active case finding methods and those with passive case find-
ing methods. Generally, in active case finding, children with
birth defects are identified through review and abstraction of
medical records at data sources, which may include birth and
pediatric hospitals, prenatal diagnostic offices, subspecialty
offices and other sources; in passive case finding, children
with birth defects are identified and reported to the program
from administrative datasets at the sources. Some passive
programs verify reported diagnoses through subsequent
medical record review. Maternal race/ethnicity was catego-
rized as: non-Hispanic White, non-Hispanic Black, Hispanic,
non-Hispanic Asian or Pacific Islander, and non-Hispanic
American Indian or Alaskan Native, other, and unknown.
Infants identified as being of more than one race were
bridged to a single race category using data from the National
Center for Health Statistics, when available.
When these bridged data were not available, infants of
more than one race were assigned to the category of other
and unknown race. Maternal age at delivery was categorized
as less than 20 years, 20 to 24 years, 25 to 29 years, 30 to 34
years, 35 to 39 years, 40 or more years, and unknown. Gesta-
tional age was categorized as term (37 weeks or greater), pre-
term (32–36 weeks), very preterm (less than 32 weeks), and
unknown. Birth weight was categorized as normal (2500 gm
or more), low (1500–2499 gm), very low (less than 1500
gm), and unknown. Plurality was categorized as singleton,
twin, triplet or higher multiple, and unknown.
The percentile for each newborn HC value from the
eight programs that provided these data was calculated
using the INTERGROWTH-21st international standards for
newborn weight, length, and head circumference by gesta-
tional age and sex (available at: https://intergrowth21.
tghn.org/articles/international-standards-newborn-weight-
length-and-head-circumference-gestational-age-and-sex-
newborn-cross-sectional-study-inte/). The INTERGROWTH-21st
standards include reference values for term, preterm, and
very preterm newborns. The percentile for each HC value tak-
en beyond the birth hospitalization from the programs that
provided these data was calculated using the World Health
Organization Child Growth Standards (available at: http://
www.who.int/childgrowth/standards/hc_for_age/en/). For
those cases where HC measurements were not available (less
than 1% of cases), the percentile values provided by the state
programs were used. Percentiles for HC were categorized as
less than 3rd percentile, 3rd to less than 5th percentile, 5th to
less than 10th percentile, and greater or equal to 10th percen-
tile. Percentiles for HC were not calculated for infants less
than 24 weeks gestation or greater than 42 weeks gestation
because reference standards for these infants were not avail-
able through INTERGROWTH-21.
Additional conditions that might contribute to micro-
cephaly included other birth defects (neural tube defects,
holoprosencephaly, craniosynostosis, and conjoined twins),
chromosomal abnormalities and/or clinical syndromes
(including fetal alcohol syndrome), and non-Zika in utero
infections. All chromosomal abnormalities, clinical syn-
dromes, and in utero infections were included as possibly
contributing regardless of whether they were known to be
associated with microcephaly. Cases with more than one
additional contributing condition were included in each
category for which they had a condition.
STATISTICAL ANALYSIS
Data were pooled across thirty programs and the unad-
justed prevalence of microcephaly was estimated as the
number of reported cases divided by the total live birth
population from the corresponding time period overall
and by maternal and infant characteristics (Mason et al.,
2005). The 95% confidence intervals (CIs) around all
prevalence estimates were calculated using the Clopper-
Pearson method (Clopper and Pearson, 1934). Prevalence
estimates for microcephaly by plurality and gestational age
categories (estimates by gestational age category were
restricted to singleton infants only) were also stratified by
maternal race/ethnicity. To assess variability in the preva-
lence of microcephaly across programs, the mean, median,
interquartile (25th to 75th percentile) and interdecile (10th
to 90th percentile) ranges were calculated overall, by case
finding methodology (active, passive), and by race/ethnici-
ty. A similar analysis was performed for HC percentiles
with the mean, median, interquartile and interdecile
ranges calculated by gestational age category.
Results
In Table 1, the counts, unadjusted prevalence estimates,
and 95% CIs for microcephaly are presented using
pooled data for 2009 to 2013 from all 30 participating
birth defects surveillance programs. The total surveillance
population covered over 11 million live births during this
time period. The pooled unadjusted prevalence for
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microcephaly was 8.7 per 10,000 live births (95% CI, 8.5–
8.9), or approximately 1 in 1150 births.
MATERNAL AND INFANT CHARACTERISTICS
Prevalence estimates for microcephaly (per 10,000 live
births) were lowest among non-Hispanic Whites (6.5) and
non-Hispanic Asian or Pacific Islanders (7.6), and highest
among non-Hispanic Blacks (11.2) and Hispanics (11.9).
Prevalence estimates (per 10,000 live births) by maternal
age followed a U-shaped pattern with the highest esti-
mates observed in the youngest (less than 20 years) and
oldest (40 years or greater) age categories (11.5 and 13.2,
respectively). This U-shaped pattern was generally consis-
tent across all race/ethnicity groups (data not shown).
TABLE 1. Microcephaly Counts,a Prevalence per 10,000 Live Births, and 95% CIs for 30 Birth Defects Surveillance Programs,b 2009 to 2013
Cases Live births
n (%) n (%) Prev 95% CI
Total cases 9,678 (100.0) 11,110,665 (100.0) 8.7 8.5-8.9
Maternal race/ethnicity
Non-Hispanic White 3,856 (39.8) 5,973,376 (53.8) 6.5 6.3-6.7
Non-Hispanic Black 1,972 (20.4) 1,758,491 (15.8) 11.2 10.7-11.7
Hispanic 3,071 (31.7) 2,585,605 (23.3) 11.9 11.5-12.3
Non-Hispanic Asian or Pacific Islander 429 (4.4) 566,353 (5.1) 7.6 6.9-8.3
Non-Hispanic American Indian or Alaska Native 54 (<1.0) 51,646 (<1.0) 10.5 7.9-13.6
Maternal age (years)
<20 1,094 (11.3) 955,420 (8.6) 11.5 10.8-12.1
20-24 2,506 (25.9) 2,608,005 (23.5) 9.6 9.2-10.0
25-29 2,487 (25.7) 3,142,705 (28.3) 7.9 7.6-8.2
30-34 2,010 (20.8) 2,765,901 (24.9) 7.3 7.0-7.6
35-39 1,089 (11.3) 1,312,477 (11.8) 8.3 7.8-8.8
401 426 (4.4) 322,730 (2.9) 13.2 12.0-14.5
Infant sex
Male 4,288 (44.3) 5,685,094 (51.2) 7.5 7.3-7.8
Female 5,371 (55.5) 5,425,361 (48.8) 9.9 9.6-10.2
Gestational age
Term birth (371 weeks) 6,200 (64.1) 9,960,699 (89.6) 6.2 6.1-6.4
Preterm birth (32 - 36 weeks) 2,271 (23.5) 933,452 (8.4) 24.3 23.3-25.4
Very preterm birth (<32 weeks) 1,088 (11.2) 187,601 (1.7) 58.0 54.6-61.5
Birth weight
Normal birth weight (2,5001 grams) 5,115 (52.9) 10,169,612 (91.5) 5.0 4.9-5.2
Low birth weight (1,500-2,499 grams) 3,140 (32.4) 760,346 (6.8) 41.3 39.9-42.8
Very low birth weight (<1,500 grams) 1,243 (12.8) 167,771 (1.5) 74.1 70.0-78.3
Plurality
Singleton 9,130 (94.3) 10,715,456 (96.4) 8.5 8.3-8.7
Twin 455 (4.7) 378,151 (3.4) 12.0 11.0-13.2
Triplet or higher 27 (<1.0) 15,645 (<1.0) 17.3 11.4-25.1
aCategories of missing/other/unknown are not shown.
bStates and territories with surveillance programs contributing to the table: Arkansas, Colorado, Delaware (2009-2012), Florida, Georgia (Metro-
politan Atlanta), Hawaii (2012), Illinois, Iowa, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Missouri,
Nebraska, Nevada, New Jersey, New York, North Carolina, North Dakota, Oregon, Puerto Rico (2013), Rhode Island, South Carolina, Texas,
Utah, West Virginia, Wisconsin
Prev, prevalence; CI, Confidence Interval.
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The estimated prevalence of microcephaly increased
with decreasing gestational age and with decreasing birth
weight. For gestational age, the estimated prevalence (per
10,000 live births) was highest among very preterm births
at less than 32 weeks gestation (58.0) and lowest among
term births at 37 weeks or more gestation (6.2). For birth
weight, the estimated prevalence (per 10,000 live births)
was highest among infants with very low birth weight of
less than 1500 gm (74.1) and lowest among infants with
normal birth weight of 2500 gm or greater (5.0). The esti-
mated prevalence of microcephaly (per 10,000 live births)
also was higher among twins (12.0) and triplets or higher
multiples (17.3) compared with that for singletons (8.5).
Because race/ethnicity can be associated with the dis-
tribution of preterm and multiple births in a population,
microcephaly prevalence estimates for these characteris-
tics were stratified by maternal race/ethnicity (Table 2).
Prevalence estimates of microcephaly increased with
decreasing gestational age among singleton births within
every maternal race/ethnicity category, although the CIs
were particularly wide for non-Hispanic American Indians
and Alaska Natives due to the small number of affected
infants. Similarly, prevalence estimates for twins and trip-
lets or higher multiples were generally greater compared
with singletons across maternal racial/ethnic categories.
CASE FINDING METHODOLOGY
In Table 3, the mean with standard deviation, median
(P50), interquartile interval range (P25–P75) and interde-
cile range (P10–P90) for the prevalence estimates of
microcephaly are presented for birth defects surveillance
programs by type of case finding methodology (active, pas-
sive) stratified by maternal race/ethnicity. In this analysis,
each program carried an equal weight regardless of popu-
lation size. The accompanying figure displays the mean
(circle), median (middle vertical bar), interquartile range
(outer vertical bars), and interdecile interval (horizontal
lines). The vertical width of each box represents the per-
cent of total cases contributed by each race/ethnicity
group. Non-Hispanic Whites are shown in green, non-
Hispanic Blacks in pink, Hispanics in blue, and total for all
race/ethnicities in white. Race/ethnicity categories that
provided less than 10% of the total cases are not shown.
A visual explanation of a similar figure was presented in
the 2015 NBDPN Annual Report (Mai et al., 2015).
Among programs with active case finding, the mean
estimated prevalence of microcephaly (per 10,000 live
births) was 7.3 and the median was 6.7, with 80% of pro-
grams reporting a prevalence between 3.4 and 12.1 (Table
3). Among programs with passive case finding, the mean
estimated prevalence of microcephaly (per 10,000 live
births) was 7.7 and the median was 6.6, with 80% of pro-
grams reporting a prevalence between 1.9 and 18.7. The
variability in prevalence estimates, as indicated by the
width of the interdecile range, was greater for birth
defects surveillance programs with passive compared with
active case finding for all race/ethnicity categories except
Hispanic ethnicity. Programs that used active case finding
TABLE 4. Microcephaly Countsa for Select Variables, Nine Birth Defects Sur-
veillance Programs,b 2009 to 2013
Cases
n (%)
Total cases 4,766 (100.0)
Time at which earliest HC measurements
were takenc
Measured at birth 4,067 (98.4)
Measured beyond the birth hospitalization 51 (1.2)
Unknown 17 (0.4)
HC percentilesd
HC <3rd percentile for age and sex 1,320 (27.8)
HC 3rd to <5th percentile for age and sex 253 (5.3)
HC 5th to <10th percentile for age and sex 494 (10.4)
HC 10th percentile for age and sex 1,983 (41.8)
Unknown HC percentile 696 (14.7)
Certainty of diagnosise
Possible/probable 205 (5.3)
Definite 3,646 (94.7)
Causesf
Documented cause 1,344 (29.5)
Chromosomal abnormality and/or
syndromeg
1,042 (22.9)
Non-Zika in utero infection 100 (2.2)
Other birth defect potentially associated
with microcephalyh
304 (6.7)
No documented cause 3,206 (70.5)
aThe total counts for each variable differ because some programs
were unable to provide all of the variables.
bStates and territories with surveillance programs contributing to the table:
Georgia (Metropolitan Atlanta), Massachusetts, Michigan, Minnesota,
North Carolina, Puerto Rico (2013 only), Rhode Island, Texas, Utah.
cIncludes only cases with an HC measurement available from 9 birth
defects surveillance programs (n 5 4,135).
dIncludes data for eight birth defects surveillance programs (n 5
4,746); one program was excluded because their case definition
required an HC less than 3rd percentile.
eIncludes data for six birth defects surveillance programs (n5 3,851).
fIncludes data for seven birth defects surveillance programs (n 5
4,550). Cases with more than one potential cause are included in
each category for which they had a condition.
gIncludes fetal alcohol syndrome.
hIncludes neural tube defects, holoprosencephaly, craniosynostosis,
and conjoined twins.
HC, Head Circumference.
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methods reported the highest mean prevalence (per
10,000 live births) among Hispanics (9.9). Hispanics also
accounted for the largest proportion of total cases among
programs with active case finding. The next highest mean
prevalence (per 10,000 live births) among programs with
active case finding was for non-Hispanic Blacks (8.6) fol-
lowed by non-Hispanic Whites (5.6).
Programs that used passive case finding methods
reported the highest mean prevalence (per 10,000 live
births) among non-Hispanic Blacks (11.5), followed by His-
panics (7.1) and non-Hispanic Whites (6.2). Non-Hispanic
Whites accounted for the largest proportion of total cases
among these programs. The median estimated prevalence
of microcephaly among programs with active and those
with passive case finding were similar for all race/ethnici-
ty categories except non-Hispanic Black. Non-Hispanic
Black was also the race/ethnicity category that contributed
the lowest proportion of cases regardless of case finding
methodology. For both types of programs, the median
prevalence estimates were lower than the mean estimates,
presumably because the median value is less influenced
by outliers and less subject to skewing by data from pro-
grams with very high prevalence estimates.
ADDITIONAL DATA ON MICROCEPHALY DIAGNOSES
Additional data on microcephaly diagnoses provided by
nine birth defects surveillance programs are presented in
Table 4. Six of the nine programs provided information on
the certainty of the microcephaly diagnosis. Almost 95%
of the cases reported by these six programs were
considered to have a definite microcephaly diagnosis;
5.3% (205/3851) were considered to have a possible/
probable diagnosis. Seven programs were able to provide
data on additional conditions that might contribute to
microcephaly. Almost 30% of cases from these programs
had at least one additional contributing condition; 22.9%
had a chromosomal abnormality or syndrome, 2.2% had
documentation of a non-Zika in utero infection, and 6.7%
had other birth defects (neural tube defects, holoprosence-
phaly, craniosynostosis, or conjoined twins).
One of the nine programs was dropped from the analysis
of HC percentiles because their case definition required that
cases have an HC less than the 3rd percentile for gestational
age and sex to be included in the surveillance. Among the
remaining eight programs, 27.8% of cases had a HC measure-
ment less than 3rd percentile; 41.8% had a HC measurement
greater than or equal to the 10th percentile. Head circumfer-
ence percentiles could not be calculated for 14.7% of cases
from these eight programs due to missing HC measurements,
sex, or gestational age values, or because the infants were
less than 24 weeks or greater than 42 weeks gestation at
birth. Slightly more than 98% of the HC measurements pro-
vided were taken during the birth hospitalization.
Analysis of the variability of HC percentiles by gesta-
tional age category is presented for seven programs in
Table 5. The figure accompanying Table 5 displays the
mean (circle), median (middle vertical bar), interquartile
range (outer vertical bars), and interdecile range (horizon-
tal lines) for HC percentiles. The one program that provid-
ed only the number of cases within each HC percentile
TABLE 5. Microcephaly HC Percentiles:a Measures of Central Tendency and Dispersion by Gestational Age for Seven Birth Defects Surveillance Programs,b 2009
to 2013
Gestational age HC percentiles
Term birth (371 weeks) Mean (SD)
P50 (P10-P90)
(P25-P75)
22.2 (28.0)
8.7 (0.2-70.2)
(1.4-34.5)
Preterm birth
(32 - 36 weeks)
Mean (SD)
P50 (P10-P90)
(P25-P75)
23.4 (29.3)
8.7 (0.1-75.9)
(1.6-36.1)
Very preterm birth
(< 32 weeks)
Mean (SD)
P50 (P10-P90)
(P25-P75)
37.6 (31.9)
29.0 (1.5-86.2)
(7.4-65.2)
In the figure, the circle indicates the mean HC percentile, the middle vertical bar indicates the median HC percentile, the outer vertical bars
indicate the interquartile range of HC percentiles, and the horizontal lines indicate the interdecile range of HC percentiles.
aLimited to microcephaly cases with head circumference measurements taken at birth; includes twins and higher multiples.
bStates with surveillance programs contributing to the table: Georgia (Metropolitan Atlanta), Michigan, Minnesota, North Carolina, Rhode Island,
Texas, Utah.
P10, 10th percentile; P25, 25th percentile; P50, 50th percentile (Median); P75, 75th percentile; P90, 90th percentile; SD, Standard Deviation;
HC, Head Circumference.
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category was dropped from this analysis. In general, the
mean HC percentile increased with decreasing gestational
age (22.2 among term births, 23.4 among preterm births
and 37.6 among very pretem births). The median HC per-
centile was the same for term and preterm births (8.7)
but much higher for very preterm births (29.0). While the
interdecile ranges were similar for all three groups, the
interquartile range for very preterm births was much wid-
er (7.4–65.2) than for term or preterm births (1.4–34.5
and 1.6–36.1, respectively).
Discussion
The pooled estimated prevalence of microcephaly from
2009 to 2013 among 30 population-based birth defects
surveillance programs in the United States was 8.7 per
10,000 live births (95% CI, 8.5–8.9). Worldwide, the
reported prevalence of microcephaly varies widely. The
European Surveillance of Congenital Anomalies (EURO-
CAT) reported an overall prevalence of microcephaly of
2.85 per 10,000 live births (95% CI, 2.69–3.02) among
full member registries for birth years 2008 to 2012
(http://www.eurocat-network.eu/ACCESSPREVALENCEDATA/
PrevalenceTables). Among population-based programs
included in the 2014 annual report of the International
Clearinghouse for Birth Defects, the prevalence estimates
for microcephaly for the most recent available birth year
(2011, 2012, or 2013) varied widely from 0.42 to 21.24
per 10,000 live births (http://www.icbdsr.org/filebank/
documents/ar2005/Report2014.pdf).
The data in this report demonstrate several factors
that could contribute to the observed variation in the
prevalence of microcephaly across U.S. birth defects sur-
veillance programs. While there was little difference in the
median prevalence estimates of microcephaly among pro-
grams with active versus passive surveillance methods, the
estimates among programs with active case finding gener-
ally showed less variability. This may be due to a combina-
tion of more rigorous case finding and confirmation of
suspected cases. A higher estimated prevalence of defects
other than microcephaly by programs with active com-
pared with passive case finding has been demonstrated,
presumably reflecting more complete case ascertainment
(Parker et al., 2010; Mai et al., 2015).
In this issue of the journal, investigators with the Utah
Birth Defect Network (UBDN) evaluated their ascertain-
ment of microcephaly (Steele et al., 2016). Their results
demonstrated the variability of ascertainment depending
on the source and method of case finding. The UBDN uses
a combination of active and passive case finding methods.
They found that 53% of all potential cases of microcephaly
reported to the UBDN were subsequently confirmed as
true cases. The sources of case ascertainment with the
highest positive predictive value for confirmed microceph-
aly included tertiary neonatal intensive care units and
pediatric specialty clinics including genetics and ophthal-
mology. Approximately 50% of reports from vital records
and hospital discharge data were subsequently confirmed
to have microcephaly. Cases reported by multiple sources
were more likely to be true cases of microcephaly.
The distribution of HC percentiles among birth defects
surveillance programs that were able to submit these
data demonstrates wide variation in the clinical definition
of microcephaly. Almost 42% of the cases had an HC
greater than or equal to the 10th percentile for age and
sex. Such differences in the definition of microcephaly
may account for much of the variation in prevalence esti-
mates across surveillance programs, and is one reason
that surveillance for microcephaly is considered particu-
larly problematic. Identification of children with mention
of microcephaly in the medical record, the approach
taken by many birth defects surveillance programs, will
include children with a wide range of HC percentiles. In
contrast, identification of all children with an HC below a
certain percentile value would inevitably include some
children who are constitutionally small but otherwise
clinically normal, and currently is not logistically practical
on a population basis.
The data in this report show a striking increase in
the prevalence of microcephaly with decreasing gesta-
tional age and birth weight. Reference data for growth
parameters at birth for very preterm infants tend to be
based on smaller samples than for term infants, which
may affect the precision of the reference values. The
small size of these infants overall also might lead to
increased mention of small head size in the medical
record relative to that for larger preterm or term infants.
Regardless of the accuracy of the measurement or diag-
nosis, variations in the proportion of preterm infants and
low birth weight infants in populations could contribute
to differences in the resulting estimates of the preva-
lence of microcephaly.
The estimated prevalence of microcephaly in these
data also varied by maternal race/ethnicity, maternal age,
and plurality. Children of Hispanic and non-Hispanic Black
mothers had a substantially higher estimated prevalence
of microcephaly compared with children of non-Hispanic
White mothers and a moderately higher prevalence com-
pared with children of non-Hispanic Asian or Pacific Island
mothers. The increased variability among prevalence esti-
mates for Hispanics from programs using active case find-
ing methods may partly be driven by the high proportion
of this ethnic group in the active program that contributed
the largest number of microcephaly cases. The fact that
the median prevalence estimate among non-Hispanic
Blacks was the highest regardless of ascertainment meth-
od supports the finding of a true higher prevalence of
microcephaly in non-Hispanic Blacks.
As a result, the racial/ethnic distribution of mothers
giving birth in different populations could contribute to
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differences in observed prevalence estimates for micro-
cephaly. A U-shaped distribution of microcephaly preva-
lence by maternal age was apparent for all racial/ethnic
groups examined, indicating that the age distribution of
mothers in different populations also could contribute to
differences in observed prevalence estimates. Similarly, the
proportion of mothers giving birth to twin or higher multi-
ple infants in different populations also could affect the
estimated prevalence of microcephaly. While these deliver-
ies generally constitute a small proportion of most popula-
tions, the increasing use of artificial reproductive
technology and resultant increase in multiple births may
vary across populations.
CONCLUSIONS
The recent spread of Zika virus highlights the critical role
that birth defects surveillance programs can play in
response to an emerging epidemic or other public health
threat affecting mothers and infants. This includes charac-
terizing the public health impact of an exposure and moni-
toring the effects of prevention efforts. High quality
population-based birth defects surveillance data can sup-
port a timely response to these threats. However, few birth
defects surveillance programs in the United States current-
ly have the infrastructure, resources, and personnel in
place to conduct “rapid” surveillance for birth defects
while simultaneously ensuring accuracy and completeness.
Timeliness of reporting, case ascertainment, and data col-
lection are all areas of potential improvement. The NBDPN
continues to develop standards and tools to support pro-
grams to achieve this goal. In the absence of a nationwide
population-based registry for birth defects, the data col-
lected from state and territorial birth defects surveillance
programs through the NBDPN provides the largest source
of data regarding the prevalence of birth defects, including
microcephaly, in the United States
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